003220.KS
Daewon Pharmaceutical Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 7,700.00
−0.77%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 16.74x
- P/E 2027E
- 12.65x
- P/E 2028E
- 8.89x
- P/S forward
- 0.95x
Trailing multiples
Trailing twelve months
- P/E TTM
- 62.82x
- PEG TTM
- —
- Price / book
- 0.62x
- Price / sales
- 0.27x
- Price / cash flow
- 6.57x
Enterprise value
- Enterprise value
- KRW 296.2B
- EV / sales
- 0.48x
- EV / EBITDA
- -7.32x
- EV / EBIT
- -4438.39x
- Market cap
- KRW 165.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026